Announcement of a License Option and Research Collaboration Agreement with Servier 2026/08/31 Notice Read
Our President & CEO, Mr. Hideaki Sato, Will Speak at RNA Leaders APAC 2026 2026/08/18 Event > Notice Read
GuNA-Related Research Article Featured on the Cover of Organic & Biomolecular Chemistry 2026/08/17 Notice > Interview Read
Where Are Nucleic Acid Therapeutics Heading? — Trends in Next-Generation Drug Discovery and Luxna Biotech’s Perspective (Featuring a Contribution by our President & CEO, Hideaki Sato) 2026/06/12 Notice > Interview Read
Luxna Biotech and KH Neochem Launch Joint Research to Advance Next-Generation Deliverable Nucleic Acid Therapeutics 2026/03/30 Notice Read
Announcement of License Agreement with Inabata & Co., Ltd. regarding the Manufacture and Sales of the Xeno-Modified Nucleic Acid Amidite “GuNA™” 2026/03/13 Notice Read
